Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple interventions for prevention, early diagnosis, and treatment of esophageal squamous cell carcinoma
ChiCTR-PRC-09000452Phase 4Completed
- Sponsor
- Beijing Friendship Hospital
- Start
- Jul 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of enalapril and aspirin in Esophageal Squamous Cell Carcinoma (ESCC) (3 arms), sponsored by Beijing Friendship Hospital. Primary endpoints: Parameters in endoscopic performance and Parameters of pathology. Started Jul 2009; status: completed.
02
Drugs
enalaprilaspirin
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on ChiCTR-PRC-09000452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-09000452.